Viewing StudyNCT00141297



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00141297
Status: COMPLETED
Last Update Posted: 2016-01-05
First Post: 2005-08-30

Brief Title: A Study Of Oral Palbociclib PD-0332991 A Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Lymphoma Non-Hodgkin
Neoplasms
Keywords:
Name View
Advanced cancer View